Recursion Pharmaceuticals Inc. News
Can This Leading Drug Developer Stock Live Up to the Hype?
The drug developer aims to build novel maps of biology. What the heck does that mean, exactly?
Cathie Wood Watch: Ark Buys Healthcare/Tech Stocks
The return of Wood's flagship Ark Innovation ETF lagged behind the S&P 500 for the five years through July 5.
Is This Synthetic Biology Pioneer On The Right Track?
Amyris is showing progress in one key area, but it may not be enough.
'Pharma Bro' Martin Shkreli's Crypto Conversion Turns Sour
The disgraced investor and convicted felon launched a cryptocurrency last July after his release from prison.
Over 1.7 Million Fords And Lincolns Are At Risk Of Being Recalled
The National Highway Transit Safety Administration received over 50 complaints over brake hose ruptures.